Plasma ascorbic acid: measurement, stability and clinical utility revisited.
Chung WY, Chung JK, Szeto YT, Tomlinson B, Benzie IF
Purpose
Conclusion
Studies (3)
Purpose
The purpose of this study was to compare the precision and sensitivity of HPLC and FRASC when measuring levels of ascorbic acid in heparinated plasma specimens. Plasma was stored at -70 degrees C prior to analysis.
Summary of Findings
Both HPLC and FRASC showed a high level of precision and sensitivity (detection limits of 1.0 umol/L and 3.0 umol/L, respectively), with respect to ascorbic acid detection. No significant differences were found between the two detection methods when matched plasma specimens were subjected to each method on the same day.
Biospecimens
FluidPlasmaPreservation Types
FrozenDiagnoses
Not specifiedPlatforms
Small moleculeHPLCSmall moleculeClinical chemistry/auto analyzerPre-analytical Factors
Classification Pre-Analytical Factor Value(s) HPLC Specific Technology platform FRASC
Purpose
The purpose of this study was to determine the most suitable anticoagulant for use when measuring ascorbic acid levels in plasma via FRASC assay. Levels were measured after storage at -70 degrees C for 0-10 days.
Summary of Findings
Use of heparin as an anticoagulant resulted in stable ascorbic acid levels, even after storage for 10 days at -70 degrees C. On the other hand, after less than 30 minutes, EDTA plasma specimens had significantly lower ascorbic acid concentrations (p<0.05) when compared to paired heparinized plasma. Stability of ascorbic acid in fluoride-oxalate and citrate plasma was slightly but not significantly lower than in heparinized plasma.
Biospecimens
FluidPlasmaFluidBloodPreservation Types
FrozenDiagnoses
Not specifiedPlatforms
Small moleculeClinical chemistry/auto analyzerPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Acquisition Anticoagulant CitrateEDTAFluoride-oxalateHeparinStorage Storage duration 1 d10 d5 dLess than 30 min
Purpose
The purpose of this study was to determine if exposure to artificial light, storage at different temperatures, or prolonged exposure of ascorbic acid to erythrocytes (1-24 hours) affects its stability in heparinized specimens.
Summary of Findings
Exposure of chilled plasma specimens to artificial light did not result in any significant differences in ascorbic acid levels from specimens kept in the dark. Storage of heparinized blood for up to 24 hours between collection and centrifugation did not significantly affect ascorbic acid levels, indicating prolonged contact with erythrocytes has no effect. However, after storage for 24 hours at RT, ascorbic acid levels decreased by 60%. Similarly, storage for 24 h, at 4 or -20 degrees C, decreased ascorbic acid levels by 20% suggesting storage below -20 degrees C is necessary for ascorbic acid stability.
Biospecimens
FluidPlasmaFluidBloodPreservation Types
FrozenDiagnoses
Not specifiedPlatforms
Small moleculeClinical chemistry/auto analyzerPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Acquisition Anticoagulant HeparinBiospecimen Aliquots and Components Blood and blood products PlasmaWhole bloodBiospecimen Aliquots and Components Centrifugation Centrifugation delays investigatedStorage Storage conditions Exposure to artificial lightStorage in the darkStorage Storage duration 1 h2 h24 h6 hStorage Storage temperature -20 degrees C4 degrees CRT